New Hope For Lung Cancer Patients — FDA Approves Drug Combination Opdivo And Yervoy For First Course Treatment

Published Jun 1, 2020

New Hope For Lung Cancer Patients — FDA Approves Drug Combination Opdivo And Yervoy For First Course Treatment

A new drug combination has been approved by the FDA for the treatment of lung cancer. This marks a historic development in research, but an expert says there's still more to be done

NOW
PLAYING
New Hope For Esophageal Cancer Patients -- Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer
NOW
PLAYING
How Does Bevacizumab (Avastin) Work As Part of Ovarian Cancer Treatment?
NOW
PLAYING
Ovarian Cancer Treatment during the COVID-19 Pandemic
NOW
PLAYING
Lung Cancer Drug Tagrisso Shows Real Benefit For Early Stage Lung Cancer Patients With EGFR Mutation
NOW
PLAYING
What Happens After An Ovarian Cancer Diagnosis?
NOW
PLAYING
Record Numbers of Cancer Drugs Approved- But Leading Experts Say Vital Clinical Trials Could Drop Off Hugely Due To COVID-19
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.